GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB

被引：1

作者：

Lassman, A. ^{[1
]}

Alexander, B. ^{[2
,3
]}

Berry, D. ^{[4
]}

Buxton, M. ^{[5
]}

Cavenee, W. ^{[6
]}

Colman, H. ^{[7
]}

De Groot, J. ^{[8
]}

Ellingson, B. ^{[9
]}

Gordon, G. ^{[5
]}

Hyddmark, E. M., V ^{[5
]}

Khasraw, M. ^{[10
]}

Lim, M. ^{[11
]}

Mellinghoff, I ^{[12
]}

Mikkelsen, T. ^{[13
]}

Perry, J. ^{[14
]}

Powell, A. ^{[5
]}

Sulman, E. ^{[15
]}

Tanner, K. ^{[16
]}

Weller, M. ^{[17
]}

Yung, W. K. A. ^{[18
]}

Blondin, N. ^{[19
]}

Brenner, A. ^{[20
]}

Butt, O. ^{[21
]}

de la Fuente, M., I ^{[22
]}

Drappatz, J. ^{[23
]}

Iwamoto, F.

Kim, L. ^{[24
]}

Lee, E. ^{[25
]}

Mantica, M. ^{[26
]}

Nabors, B. ^{[27
]}

Newton, H. ^{[28
]}

Schiff, D. ^{[29
]}

Walbert, T. ^{[13
]}

Weathers, S. ^{[30
]}

Cloughesy, T. ^{[9
]}

Wen, P. Y. ^{[31
]}

机构：

[1] Columbia Univ, New York, NY USA

[2] Harvard Med Sch, Boston, MA USA

[3] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[4] Berry Consultants, Austin, TX USA

[5] Global Coalit Adapt Res, Larkspur, CA USA

[6] UCSD, La Jolla, CA USA

[7] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[8] UCSF, San Francisco, CA USA

[9] UCLA, Los Angeles, CA USA

[10] Duke Univ, Med Ctr, Durham, NC USA

[11] Stanford Univ, Stanford, CA USA

[12] Mem Sloan Kettering, New York, NY USA

[13] Henry Ford Hlth, Detroit, MI USA

[14] Univ Toronto, Toronto, ON, Canada

[15] NYU, Grossman Sch Med, New York, NY USA

[16] Natl Brain Tumor Soc, Newton, MA USA

[17] Univ Hosp Zurich, Zurich, Switzerland

[18] UT MD Anderson Canc Ctr, Houston, TX USA

[19] Yale Univ, New Haven, CT USA

[20] Texas Oncol, Austin, TX USA

[21] Washington Univ, St Louis, MO USA

[22] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA

[23] Hillman Canc Ctr, Pittsburgh, PA USA

[24] Mt Sinai Hosp, New York, NY USA

[25] Dana Farber Canc Inst, Boston, MA USA

[26] Univ Pittsburgh, Pittsburgh, PA USA

[27] Nivers Alabama Birmingham, Birmingham, AL USA

[28] Univ Hosp Cleveland, Med Ctr, Cleveland, OH USA

[29] Univ Virginia, Charlottesville, VA USA

[30] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[31] Dana Farber Canc Inst, Larkspur, CA USA

来源：

NEURO-ONCOLOGY | 2024年 / 26卷

关键词：

D O I：

10.1093/neuonc/noae144.079

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OS09.7.A

引用

页码：V26 / V27

页数：2

共 50 条

[41] Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial)
Mallick, Supriya
Kunhiparambath, Haresh
Gupta, Subhash
Benson, Rony
Sharma, Seema
Laviraj, M. A.
Upadhyay, Ashish Datt
Julka, Pramod Kumar
Sharma, Dayanand
Rath, Goura Kishor
JOURNAL OF NEURO-ONCOLOGY, 2018, 140 (01) : 75 - 82
[42] A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM)
Kleinberg L.
Ye X.
Supko J.
Stevens G.H.J.
Shu H.-K.
Mikkelsen T.
Lieberman F.
Lesser G.J.
Lee E.
Grossman S.A.
Journal of Neuro-Oncology, 2023, 165 (3) : 499 - 507
[43] TTFIELDS IN ROUTINE CLINICAL CARE OF NEWLY DIAGNOSED GBM PATIENTS IN GERMANY - FIRST REPORT ON THE FULLY ENROLLED TIGER STUDY POPULATION
Baehr, Oliver
Tabatabai, Ghazaleh
Fietkau, Rainer
Goldbrunner, Roland
Glas, Martin
NEURO-ONCOLOGY, 2020, 22 : 59 - 59
[44] EFFICACY OF TTFIELDS IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) - SUB-GROUP ANALYSIS OF THE EF-14 TRIAL
Ram, Zvi
Kim, Chae-Yong
Zhu, Jay-Jiguang
NEURO-ONCOLOGY, 2020, 22 : 58 - 58
[45] Phase 2 clinical trial of dianhydrogalactitol (VAL-083) in patients with newly diagnosed MGMT-unmethylated GBM.
Chen, Zhong-ping
Guo, Cheng-cheng
Yang, Qun-ying
Li, Jia-wei
Wu, Shao-xiong
Langlands, John
Johnson, Gregory
Kwan, Claire
Kanekal, Sarath
Schwartz, Richard
Bacha, Jeffrey
Steino, Anne
Brown, Dennis
CANCER RESEARCH, 2021, 81 (13)
[46] NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN NEWLY DIAGNOSED ELDERLY PATIENTS (PTS) WITH GLIOBLASTOMA (GBM) (NUTMEG): TRIAL IN PROGRESS
Khasraw, M.
McDonald, K.
Yip, S.
Verhaak, R. G.
Heimberger, A. B.
Hall, M.
Barnes, E.
Hovey, E.
Ellingson, B. M.
Lwin, Z.
NEURO-ONCOLOGY, 2018, 20 : 236 - 236
[47] Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM).
Omuro, Antonio Marcilio Padula
Beal, Kathryn
McNeill, Katharine Anne
Thomas, Alissa A.
Lin, Xuling
Kaley, Thomas Joseph
DeAngelis, Lisa Marie
Mellinghoff, Ingo K.
Diamond, Eli L.
Chan, Timothy An-thy
Young, Robert J.
Yamada, Yoshiya
Gorman, Greg
Lamson, Michael
Bavisotto, Linda M.
Karmali, Rashida A.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[48] EVALUATION OF POST-PROGRESSION TREATMENTS AFTER VAL-083 IN RECURRENT AND NEWLY DIAGNOSED GBM MGMT-UNMETHYLATED PATIENTS
Kamiya-Matsuoka, Carlos
Weathers, Shiao-Pei
Yung, W. K. Alfred
Loghin, Monica
Majd, Nazanin
Brown, Dennis
Langlands, John
Schwartz, Richard
Knight, Stephanie
Puduvalli, Vinay
de Groot, John
O'Brien, Barbara
NEURO-ONCOLOGY, 2023, 25
[49] Hypofractionated Stereotactic Radiation Therapy (HFSRT) With Concurrent Chemotherapy (CTX) in Patients With Newly Diagnosed Poor Prognosis GBM: Early Results
Ye, J. C.
Yondorf, M.
Pannullo, S. C.
Boockvar, J. A.
Schwartz, T. H.
Stieg, P. E.
Parashar, B.
Nori, D.
Chao, K. C.
Wernicke, A.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S249 - S250
[50] Adaptively randomized seamless-phase multiarm platform trial: Glioblastoma Multiforme Adaptive Global Innovative Learning Environment (GBM AGILE)
Berry, Donald A.
Graves, Todd
Connor, Jason
Alexander, Brian
Cloughesy, Timothy
Barker, Anna
Berry, Scott M.
CANCER RESEARCH, 2017, 77

← 1 2 3 4 5 →